Oxford Global is proud to present the Biopharma Asia Series taking place on 24th& 25th September 2013 in Singapore. The series is dedicated to discussing scientific trends and addressing the most pressing challenges in the Asia Biopharmaceutical industry, made up of two co-located events Biosimilars Asia Congress and the Cell Culture Asia Congress.
Over two days, these events will attract over 175 senior-level decision makers working in the biopharmaceutical industry from Asia, the US and Europe. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive platform for high-level scientific and business discussion.
Biosimilars Asia Congress
Stream 1 will explore key strategies for gaining access to emerging markets, managing the role of innovator companies and commercialising biosimilars. Our internationally renowned speakers will discuss the critical issues in manufacturing biosimilars, achieving quality by design, single use systems and the Mab biosimilar opportunity.
Stream 2 will feature case studies of the opportunities and challenges in clinical trials including implications for clinical development and patient safety, and also the latest insights into developing an efficient scale up process, demonstrating biosimilarity and CMC considerations.
Cell Culture Asia Congress
Stream 1 will examine the current trends and technologies in cell culture development and cell line optimisation. Our panel of experts will also discuss methods for overcoming the most pressing challenges in cell line performance, contamination and authentication and cell culture media.
During Stream 2 hear how industry leaders are advancing raw material management and accelerating cell line development. Do not miss out on case studies examining disposable & single use technology, risk reduction strategies and achieving optimal biotherapeutic production.
